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Aims and objective: Evaluation of safety and efﬁcacy of transcath-
eter closure of PMVSD using ADO a mid-term follow up.
Material and methods: Between September 2012 and September
2015, 150 patients underwent percutaneous PMVSD device closure
with ADO at our institution. All patient underwent clinical exam-
ination, ECG, 2D echo and TEE pre-procedure, post procedure, 1, 3,
and at 6 months follow-up. Oral steroids were given to all the
patients for 5 days or long in those with conduction disturbances
and dose was tapered over 2–3 week period.
Results: Transcatheter closure of PMVSD was attempted in 150
patients, which was successful in 150 patients (100%). There were
85 male and 65 female patients. According to color Doppler TTE
before intervention, the average end-diastolic PMVSD size was
5.24 mm. Majority (81.02%) had no residual shunt at follow-up.
Total rhythm disturbances were seen in about 6.9% (11/158) of
patients with transient junctional rhythm occurring in 9 patients
and intermittent Mobitz type I 2:1 AV block in 2 patients. In our
study, all patient were given oral steroids in post procedure period
which was continued for 1 month in these patients who experi-
enced rhythm disturbances. None of the patient developed com-
plete AV block requiring temporary or permanent pacemaker.
Conclusion: In our study of percutaneous closure of PMVSD with
the ADO incidence of high grade AV conduction disturbances is
rare and transient. The use of oral steroids over a short-termperiod
can drastically reduce the incidence of conduction disturbances.
Percutaneous closure of PMVSD with ADO can be a safe, effective,
cheap and promising option.
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Background: The elderly constitute a rapidly expanding segment of
our population and CVD becomes more prevalent with increasing
age. Evidence suggests that the proportion of patients who receive
standard secondary prevention or revascularization declines as
they age beyond the eighth decade. High incidence of complica-
tions may be due to the high prevalence of associated comorbid-
ities and late referral for revascularization. The aim of the present
study was to assess clinical characteristics, procedural details, and
intermediate term outcomes in the patients older than 80 under-
going PCI.
Method: This was a single center, randomized prospective study.
Patients equal to or above the age of 80 years (Octogenarians) both
male and female presented with symptoms and signs of acute
coronary syndrome or chronic stable angina, and planned for
percutaneous coronary intervention were included in the study.
Parameters were assessed at baseline, pre-discharge and at 6
months post-procedure. MACE (Cardiac death, non-fatal MI,
CVA, stent thrombosis, bleeding and target vessel revasculariza-
tion) was taken as primary composite end point.
Result: Patients (n = 50) were divided into 2 groups: Group I (80–85
years, n = 35, 70%) and Group II (≥85 years, n = 15, 30%). At baseline,
overall presentation with STEMI, cardiogenic shock and heart
failure were signiﬁcantly more in group II compared to group I
{53.33% GpII vs 31.42% GpI ( p < 0.001), 26.67% GpII vs 8.57% GpI
( p < 0.001), 80% GpII vs 45.71% GpI ( p < 0.001), respectively}. Inci-
dence of double and triple vessel disease were more in Group II
than in Group I {93.33% GpII vs 82.85% GpI ( p < 0.001)}. Procedural
success was signiﬁcantly decreased in Group II {94.28% GpI vs
86.67% in GpII ( p < 0.001)}. Bleeding complications signiﬁcantly
increased in Group II {46.67% GpII vs 20% GpI ( p < 0.001)}. On 6
monthly follow-up, the overall (n = 50) all-causemortalitywas 24%,
MI incidence 8% and TVR 6%. MACE were signiﬁcantly increased in
Group II {46.67% GpII vs 17.14% GpI ( p < 0.001)}.
Conclusion: PCI and stenting can be done in elderly patients (>80
years) with reasonably high success and acceptable complication
rates. Within the group, the more elderly (>85 years) have higher
risk proﬁle, lesser success and higher complications and MACE.
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Introduction: Persistent left superior vena cava (PLSVC) with
absent right SVC is a rare congenital anomaly of the vena cava,
which poses challenges during performing transvenous pacing.
We report a case of a successful biventricular pacing and deﬁbril-
lator device implantation (CRT-D) via a persistent left superior
vena in a patient with dilated cardiomyopathy and severe LV
systolic dysfunction with absent right SVC.
Case report: A 53-yr-old male patient presented to us with sudden
onset of breathlessness with orthopnea. On evaluation ECG done
showed LBBB with QRS duration of 120 ms with secondary ST-T
changes. 2D Echo done showed dilated LVwith global hypokinesia,
ventricular dyssynchrony and severe LV systolic dysfunction with
2D LVEF 15–20%. Patient was treated conservatively and later
advised coronary angiography (CAG). CAG done showed non-
obstructive coronary artery disease. Patient was later discharged
on diuretics, ACE inhibitors, spiranolactone and beta blockers.
Despite being on optimal medical therapy for 3 months patient
remained in NYHA class II, hence CRT-D implantation was
planned.
Venography done revealed a PLSVC with absent right SVC with
PLSVC draining into an extremely dilated coronary sinus. A 5 F
Judkins-type angiographic catheter (JR 4.0) was used to perform
selective coronary sinus tributaries venography via the left sub-
clavian vein. Then with the help of guide wire lateral vein was
cannulated. Retaining the wire, the angiographic catheter was
replaced with a guiding sheath, and then the left ventricular lead
successfully positioned in a lateral vein. A dual-coil active-ﬁxation
deﬁbrillator lead was positioned in the right ventricular apex,
followed by a SonR active ﬁxation lead in the right atrial free wall.
All three leads were implanted through the PLSVC. Acute thresh-
olds were checked and all leads were eventually connected to a
CRT -D device. Later ECG done showed biventricular pacing and
chest X-ray done conﬁrmed the lead positions. The patient was
discharged from the hospital without complications.
Discussion: Persistent left SVC (PLSVC) is a rare anomaly of the
venous circulation, and it occurs in 0.5% of the general population,
0.3% of healthy persons, and 4.3% of those with congenital heart
disease. In most patients with left SVC, a right SVC is present. PL
SVC with absent right SVC occurs in only 0.09–0.13% of patients
who have congenital heart defects. Although this rare condition is
frequently associated with situs inversus, our patient was situs
solitus and lacked a right SVC and had a persistent left SVC that
drained into the right atrium via an extremely dilated coronary
sinus. This condition is typically asymptomatic, usually inciden-
tally discovered during pacemaker implantation and it can com-
plicate lead placement through the subclavian approach. Although
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